Lmcg Investments, LLC Amgen Inc Transaction History

Lmcg Investments, LLC

$1.65 Billion
Q3 2024

A detailed history of Lmcg Investments, LLC transactions in Amgen Inc stock. As of the latest transaction made, Lmcg Investments, LLC holds 37,147 shares of AMGN stock, worth $9.68 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares

37,147

Previous 36,989 0.43%

Holding current value

$9.68 Million

Previous $11.6 Million 3.56%

% of portfolio

0.73%

Previous 0.68%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$309.38 - $337.38 $48,882 - $53,306	158 Added 0.43%	37,147 $12 Million
Q2 2024 Aug 09, 2024	BUY	$262.75 - $319.31 $17,078 - $20,755	65 Added 0.18%	36,989 $11.6 Million
Q1 2024 May 03, 2024	BUY	$268.87 - $324.56 $159,977 - $193,113	595 Added 1.64%	36,924 $10.5 Million
Q4 2023 Feb 07, 2024	BUY	$255.7 - $288.46 $53,952 - $60,865	211 Added 0.58%	36,329 $10.5 Million
Q3 2023 Nov 02, 2023	SELL	$218.65 - $271.46 $38,045 - $47,234	-174 Reduced 0.48%	36,118 $9.71 Million
Q2 2023 Aug 02, 2023	SELL	$214.27 - $253.37 $84,208 - $99,574	-393 Reduced 1.07%	36,292 $8.06 Million
Q1 2023 May 04, 2023	SELL	$225.79 - $275.2 $93,928 - $114,483	-416 Reduced 1.12%	36,685 $8.87 Million
Q4 2022 Feb 06, 2023	SELL	$229.03 - $291.01 $322,245 - $409,451	-1,407 Reduced 3.65%	37,101 $9.74 Million
Q3 2022 Nov 07, 2022	SELL	$224.46 - $253.15 $284,390 - $320,741	-1,267 Reduced 3.19%	38,508 $8.68 Million
Q2 2022 Aug 08, 2022	SELL	$230.71 - $256.74 $22,609 - $25,160	-98 Reduced 0.25%	39,775 $9.68 Million
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $8.74 Million - $9.67 Million	39,873 New	39,873 $9.64 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $139B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmcg Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lmcg Investments, LLC with notifications on news.

Account

Lmcg Investments, LLC Amgen Inc Transaction History